Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CSNK1E | P49674 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.36 |
| ▸ | HTR2A | P28223 | 2/20 | 0.35 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.35 |
| ▸ | OPRD1 | P41143 | 2/20 | 0.35 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.35 |
| ▸ | OPRL1 | P41146 | 2/20 | 0.35 |
| ▸ | NAAA | Q02083 | 2/20 | 0.33 |
| ▸ | NPC1 | O15118 | 2/20 | 0.33 |
| ▸ | RAB9A | P51151 | 2/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | HRH1 | P35367 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | CNR2 | P34972 | 1/20 | 0.33 |
| ▸ | CASR | P41180 | 1/20 | 0.33 |
| ▸ | SLC37A4 | O43826 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20534805 | 0.98 | CSNK1E (0.39) | CSNK1EALDH1A1SIGMAR1HTR2AOPRM1 | |
| SCHEMBL6811502 | 0.88 | CSNK1E (0.41) | CSNK1EALDH1A1OPRM1OPRD1OPRK1 | |
| SCHEMBL8709294 | 0.87 | CSNK1E (0.43) | CSNK1EALDH1A1HTR2AOPRM1OPRD1 | |
| SCHEMBL8707831 | 0.85 | ALDH1A1 (0.35) | CSNK1EALDH1A1SIGMAR1HTR2AOPRM1 | |
| SCHEMBL6811529 | 0.85 | ALDH1A1 (0.35) | CSNK1EALDH1A1SIGMAR1HTR2AOPRM1 | |
| SCHEMBL8709148 | 0.84 | ALDH1A1 (0.37) | CSNK1EALDH1A1SIGMAR1HTR2AOPRM1 | |
| SCHEMBL6540703 | 0.81 | ALDH1A1 (0.40) | ALDH1A1HTR2APOLBHRH1CASR | |
| SCHEMBL27823090 | 0.78 | LTA4H (0.41) | HTR2ANPC1RAB9ASMN1; SMN2LMNA | |
| SCHEMBL6541581 | 0.76 | NPC1 (0.42) | ALDH1A1HTR2ANPC1RAB9ASMN1; SMN2 | |
| SCHEMBL22654229 | 0.76 | LMNA (0.35) | ALDH1A1LMNACASR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12385907-B2 | Transition metal chelating beads | ROCHE DIAGNOSTICS OPERATIONS, INC. (US) | 2025-08-12 | — | — | US | claimed |
| EP-3948282-B1 | TRANSITION METAL CHELATING BEADS | ROCHE DIAGNOSTICS GMBH (DE) | 2025-04-23 | — | — | EP | claimed |
| EP-3948282-A1 | TRANSITION METAL CHELATING BEADS | Roche Diagnostics GmbH (DE) | 2022-02-09 | — | — | EP | claimed |
| US-20220009963-A1 | TRANSITION METAL CHELATING BEADS | ROCHE DIAGNOSTICS GMBH (DE) | 2022-01-13 | — | — | US | claimed |
| CN-113646634-A | Transition metal chelate beads | 豪夫迈·罗氏有限公司 | 2021-11-12 | — | — | CN | claimed |
| WO-2020201089-A1 | TRANSITION METAL CHELATING BEADS | ROCHE DIAGNOSTICS GMBH (DE) | 2020-10-08 | — | — | WO | claimed |
| EP-4707808-A2 | SUPERPARAMAGNETIC AND HIGHLY POROUS POLYMER PARTICLES FOR DIAGNOSTIC APPLICATIONS | Roche Diagnostics GmbH (DE) | 2026-03-11 | — | — | EP | disclosed |
| EP-3610262-B1 | SUPERPARAMAGNETIC AND HIGHLY POROUS POLYMER PARTICLES FOR DIAGNOSTIC APPLICATIONS | ROCHE DIAGNOSTICS GMBH (DE) | 2026-03-04 | — | — | EP | disclosed |
| US-12385907-B2 | Transition metal chelating beads | ROCHE DIAGNOSTICS OPERATIONS, INC. (US) | 2025-08-12 | — | — | US | disclosed |
| EP-3948282-B1 | TRANSITION METAL CHELATING BEADS | ROCHE DIAGNOSTICS GMBH (DE) | 2025-04-23 | — | — | EP | disclosed |
| CN-118649443-A | Superparamagnetic and highly porous polymer particles for diagnostic applications | 豪夫迈·罗氏有限公司 | 2024-09-17 | — | — | CN | disclosed |
| US-20230381743-A1 | METHOD FOR PREPARING HIGHLY POROUS POLYMER PARTICLES FOR DIAGNOSTIC APPLICATIONS | ROCHE DIAGNOSTICS OPERATIONS, INC. | 2023-11-30 | — | — | US | disclosed |
| US-11724246-B2 | Method for preparing highly porous polymer particles for diagnostic applications | ROCHE DIAGNOSTICS OPERATIONS, INC. (US) | 2023-08-15 | — | — | US | disclosed |
| EP-3610263-A1 | METHOD FOR PREPARING HIGHLY POROUS POLYMER PARTICLES FOR DIAGNOSTIC APPLICATIONS | Roche Diagnostics GmbH (DE) | 2020-02-19 | — | — | EP | disclosed |
| US-20200038839-A1 | METHOD FOR PREPARING HIGHLY POROUS POLYMER PARTICLES FOR DIAGNOSTIC APPLICATIONS | ROCHE DIAGNOSTICS OPERATIONS, INC. (US) | 2020-02-06 | — | — | US | disclosed |
| US-20200041502-A1 | SUPERPARAMAGNETIC AND HIGHLY POUROUS POLYMER PARTICLES FOR DIAGNOSTIC APPLICATIONS | ROCHE DIAGNOSTICS OPERATIONS, INC. (US) | 2020-02-06 | — | — | US | disclosed |
| CN-110741258-A | Superparamagnetic and highly porous polymer particles for diagnostic applications | 豪夫迈·罗氏有限公司 | 2020-01-31 | — | — | CN | disclosed |
| WO-2019141779-A1 | HYPERCROSSLINKING WITH DIAMINE CROSSLINKERS | F. HOFFMANN-LA ROCHE AG (CH) | 2019-07-25 | — | — | WO | disclosed |
| WO-2018189287-A1 | METHOD FOR PREPARING HIGHLY POROUS POLYMER PARTICLES FOR DIAGNOSTIC APPLICATIONS | ROCHE DIAGNOSTICS GMBH (DE) | 2018-10-18 | — | — | WO | disclosed |
| WO-2018189286-A1 | SUPERPARAMAGNETIC AND HIGHLY POROUS POLYMER PARTICLES FOR DIAGNOSTIC APPLICATIONS | ROCHE DIAGNOSTICS GMBH (DE) | 2018-10-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12385907-B2 | Transition metal chelating beads | PHOSPHO1, PIGO, C9 | CSNK1E 3358/4885ALDH1A1 2907/4885SIGMAR1 1617/4885 |
| US-20220009963-A1 | TRANSITION METAL CHELATING BEADS | PHOSPHO1, PIGO, C9 | CSNK1E 3358/4885ALDH1A1 2907/4885SIGMAR1 1617/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.